DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Clinical outcome in resistant HIV-2 infection treated with raltegravir and maraviroc.

Author(s): Armstrong-James D, Stebbing J, Scourfield A, Smit E, Ferns B, Pillay D, Nelson M

Affiliation(s): Imperial College, St. Stephens AIDS Trust, Chelsea and Westminster Hospital, London, UK.

Publication date & source: 2010-05, Antiviral Res., 86(2):224-6. Epub 2010 Mar 6.

Therapy for infection with HIV-2 remains limited. We report an HIV-2-infected patient in whom genotyping demonstrated PI, NRTI and NNRTI resistance, with a subsequent response to raltegravir- and maraviroc-based therapy. Further studies are required to assess the clinical efficacy of maraviroc in HIV-2 infection.

Page last updated: 2010-10-05

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017